SeaCrest Wealth Management’s NeoGenomics NEO Stock Holding History

SeaCrest Wealth Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-78	Closed	-$2K	–	1362
2019 Q1	$2K	Hold	78	–	–	﹤0.01%	1929
2018 Q4	$1K	Hold	78	–	–	﹤0.01%	2043
2018 Q3	$1K	Sell	78 -50	-39%	-$691	﹤0.01%	2174
2018 Q2	$2K	Hold	128	–	–	﹤0.01%	2018
2018 Q1	$1K	Hold	128	–	–	﹤0.01%	2107
2017 Q4	$1K	Buy	+128	New	+$1.18K	﹤0.01%	2117

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

SeaCrest Wealth Management's NEO Position: Q2 2019 in Review

SeaCrest Wealth Management sold out of NeoGenomics (NEO) in Q2 2019, closing a stake of 78 shares — an estimated $2K sold.

SeaCrest Wealth Management first reported a position in NEO in Q4 2017 and held it in 6 quarters. The position peaked at $2K in Q1 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q2 2019.

SeaCrest Wealth Management reported no remaining NeoGenomics position as of Q2 2019 after selling out during the quarter.
SeaCrest Wealth Management sold 78 NeoGenomics shares in Q2 2019, an estimated $2K.
SeaCrest Wealth Management first reported a position in NeoGenomics in Q4 2017 and held it in 6 quarters.
SeaCrest Wealth Management's NeoGenomics position peaked at $2K in Q1 2019.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2019.

Based on SeaCrest Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.